Physician profile
Patrick Diamond
NPI 1912411851
$7,231.70
in general payments reported to CMS, 2019-2025
31 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,119 · 2022: $1,569 · 2023: $1,459 · 2024: $1,548 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,543.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,394.08 | 2021-2025 | |
| Novo Nordisk INC | $1,340.90 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $965.48 | 2021-2025 | |
| Glaxosmithkline, LLC. | $706.77 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $539.16 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $516.71 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $381.80 | 2021-2025 | Prolia, Evenity, Repatha |
| Merck Sharp & Dohme LLC | $241.97 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Phathom Pharmaceuticals, INC. | $172.64 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $126.61 | 2022-2024 | Xarelto |
| Amarin Pharma, INC. | $103.15 | 2021-2022 | |
| Abbott Laboratories | $95.01 | 2024-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company Ltd. | $93.15 | 2022 | |
| Sanofi-Aventis U.S. LLC | $78.19 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.28 | 2021-2025 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $54.72 | 2025 | Cologuard Collection Kit |
| Organon LLC | $44.75 | 2023-2024 | Nexplanon |
| Sanofi Pasteur INC. | $39.15 | 2023 | |
| Novartis Pharmaceuticals Corporation | $37.50 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.35 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $25.89 | 2025 | Unithroid |
| Teva Pharmaceuticals USA, INC. | $24.89 | 2021 | |
| Irhythm Technologies, INC. | $20.49 | 2023 | Zio Xt Patch |
| Dexcom, INC. | $19.88 | 2025 | Dexcom G6 Transmitter |
| Averitas Pharma INC. | $18.85 | 2025 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $18.81 | 2025 | Camzyos |
| Jazz Pharmaceuticals INC. | $17.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.43 | 2023 | |
| Esperion Therapeutics, INC. | $16.91 | 2021 | |
| Chiesi USA, INC. | $16.14 | 2022 | |
| Currax Pharmaceuticals LLC | $14.09 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.